EZOFGA
Live / Applied — Third extension granted (statement of use) (as of 14 Jan 2026)
What this means for you
Not registered yet, but its 19 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98231209
- Mark type
- Stylized text
- Filed
- 19 Oct 2023
- Published for opposition
- 09 Jul 2024
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products, namely, budesonide oral suspension (BOS) for eosinophilic esophagitis (EoE)
Owner
- ViroPharma Biologics LLC, Lexington, MA, US
- ViroPharma Biologics LLC, Lexington, MA, US
Prosecution history
- 20 Jan 2026 — ASSIGNED TO EXAMINER
- 15 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2026 — SOU EXTENSION 3 GRANTED
- 14 Jan 2026 — SOU EXTENSION 3 FILED
- 14 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2025 — SOU EXTENSION 2 GRANTED
- 18 Jun 2025 — SOU EXTENSION 2 FILED
- 18 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2024 — SOU EXTENSION 1 GRANTED
- 06 Nov 2024 — SOU EXTENSION 1 FILED